Return to search

Nanoformulation of Artemisia afra and its potential biomedical applications in type 2 diabetes

>Magister Scientiae - MSc / Current research classifies Type 2 diabetes as most prevalent non-communicable diseases in South
Africa. Approximately 285 million people are affected globally with an expected increase to 595
million by the year 2035. Synthetic first-line drugs in the treatment of Type 2 diabetes, have been
shown to have an efficacy rate of approximately 43% as a result of poor drug uptake and
metabolism. Furthermore, given South Africa’s uniquely diverse botanical heritage, herbs
commonly used traditional medicine have shown promise in the treatment of Type 2 diabetes.

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:uwc/oai:etd.uwc.ac.za:11394/7715
Date January 2019
CreatorsLiebenberg, Nicole Albertha-Wade
ContributorsPearce, Brendon, Benjeddou, Mongi
PublisherUniversity of Western Cape
Source SetsSouth African National ETD Portal
LanguageEnglish
Detected LanguageEnglish
RightsUniversity of Western Cape

Page generated in 0.0021 seconds